ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01844297
Recruitment Status : Unknown
Verified April 2013 by LI Taisheng, Peking Union Medical College.
Recruitment status was:  Not yet recruiting
First Posted : May 1, 2013
Last Update Posted : May 1, 2013
Sponsor:
Information provided by (Responsible Party):
LI Taisheng, Peking Union Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2015
  Estimated Study Completion Date : December 2015